Literature DB >> 2144483

Differential effects of cardiac hypertrophy and failure on right versus left ventricular calcium activation.

C L Perreault1, O H Bing, W W Brooks, B J Ransil, J P Morgan.   

Abstract

We studied calcium responsiveness of skinned muscle preparations from the right and left ventricles of rats with cardiac hypertrophy and cardiac hypertrophy plus failure. To test the hypothesis that differences in contractile function are due to changes in myofilament calcium responsiveness, we compared preparations from spontaneously hypertensive rats with cardiac failure, spontaneously hypertensive rats without cardiac failure, and age-matched normotensive Wistar-Kyoto control rats 18-24 months of age. Rats with failure had pleural/pericardial effusions, left atrial thrombi, and right and left ventricular hypertrophy. Muscles were skinned by saponin (250 micrograms/ml) and activated with a series of calcium buffers. Data were plotted as pCa (-log[Ca2+]) versus isometric force and then fit to a modified Hill equation. Values for 50% maximal activation (calcium sensitivity), maximal calcium-activated force, and the slope of the calcium-force relation were compared. Our data indicate that with the development of hypertrophy, calcium sensitivity of left ventricular muscles remains unaffected, but maximal calcium-activated force is increased. In contrast, maximal calcium-activated force declines toward control levels with the development of left ventricular failure, despite the continued presence of significant hypertrophy. In the normotensive rats, the left ventricle is more sensitive to calcium than the right ventricle (pCa50 = 6.0 +/- 0.05 versus 5.7 +/- 0.09; p less than 0.05); however, both the calcium sensitivity and maximal calcium-activated force of the right ventricle increase with the development of compensatory hypertrophy secondary to left ventricular failure. These changes that occur in rats with cardiac hypertrophy and failure may represent important physiological adaptive mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144483     DOI: 10.1161/01.res.67.3.707

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

1.  Myocyte shape regulates lateral registry of sarcomeres and contractility.

Authors:  Po-Ling Kuo; Hyungsuk Lee; Mark-Anthony Bray; Nicholas A Geisse; Yen-Tsung Huang; William J Adams; Sean P Sheehy; Kevin K Parker
Journal:  Am J Pathol       Date:  2012-12       Impact factor: 4.307

Review 2.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

3.  Interventricular differences in myofilament function in experimental congestive heart failure.

Authors:  Rashad J Belin; Marius P Sumandea; Gail A Sievert; Laura A Harvey; David L Geenen; R John Solaro; Pieter P de Tombe
Journal:  Pflugers Arch       Date:  2011-09-17       Impact factor: 3.657

4.  Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.

Authors:  S Kim; K Ohta; A Hamaguchi; T Yukimura; K Miura; H Iwao
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 5.  Studies of prevention, treatment and mechanisms of heart failure in the aging spontaneously hypertensive rat.

Authors:  Oscar H L Bing; Chester H Conrad; Marvin O Boluyt; Kathleen G Robinson; Wesley W Brooks
Journal:  Heart Fail Rev       Date:  2002-01       Impact factor: 4.214

6.  Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.

Authors:  Aiping Liu; David Schreier; Lian Tian; Jens C Eickhoff; Zhijie Wang; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-06-06       Impact factor: 4.733

7.  Right atrial contractile dynamics are impaired in patients with postcapillary pulmonary hypertension.

Authors:  Constanze Bening; Rainer Leyh
Journal:  Exp Ther Med       Date:  2016-05-26       Impact factor: 2.447

8.  Cellular mechanism of the positive inotropic effect of hydralazine in mammalian myocardium.

Authors:  D G Hurrell; C L Perreault; L Miao; B J Ransil; J P Morgan
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 9.  Cardiac tissue structure, properties, and performance: a materials science perspective.

Authors:  Mark Golob; Richard L Moss; Naomi C Chesler
Journal:  Ann Biomed Eng       Date:  2014-08-01       Impact factor: 3.934

10.  The right ventricle: biologic insights and response to disease.

Authors:  Lori A Walker; Peter M Buttrick
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.